Search Tag: type 2 diabetes

IT Management

A-groundbreaking-ai-technology-can-screen-for-diabetes

2023 20 Nov

A team has discovered a method to test for Type 2 diabetes by having individuals speak into their smartphones.   Using an Al model developed by a U.S. team from Klick Labs, a person speaking into their smartphone for as little as 10 seconds can be tested for Type 2 diabetes. The test reveals an accuracy rate of 89% for women and 86% for men....Read more

Sepsis

Genetically-predicted-insomnia-and-risk-of-sepsis

2023 11 Oct

Insomnia, a common sleep disorder, has been linked to various adverse health outcomes, including altered immune function and elevated systemic levels of inflammatory markers, which may affect women more than men. Dysregulated immune responses can lead to conditions like sepsis, which has high morbidity and mortality. A study was conducted to determine...Read more

Cardiology Management

Cardiovascular-disease-diabetes-increase-risk-of-dementia

2022 21 Jun

Cardiometabolic diseases, including type 2 diabetes, ischaemic heart disease, heart failure or atrial fibrillation and stroke, are some of the primary risk factors for dementia. A new study published in the journal Alzheimer's & Dementia   shows that people with at least two of the diseases - type 2 diabetes, heart disease or stroke - have double the...Read more

Cardiology Management

Follow-up-reduces-risk-of-type-2-diabetes

2022 12 Apr

Type 2 diabetes can be an inherited disease, but habits can also affect a person's risk of getting it. In particular, obesity due to fatty and high-calorie foods, often in combination with limited activity, increases the risk of developing Type 2 diabetes  considerably. A new study at The Norwegian University of Science and Technology and St. Olav's...Read more

Executive Health Management

The-future-is-digital

2020 09 Mar

The debate about Artificial Intelligence (AI) versus healthcare personnel shows no sign of abating. While we can safely say that the role of physicians is not under any serious threat from technology, AI will be critical in managing data for more efficient diagnosis, workflow and patient care. ‘The Future is Digital’ offers exciting views on data...Read more

Executive Health Management

Advancing-the-understanding-and-treatment-of-type-2-diabetes

2020 09 Mar

Prof. Daniel Drucker is a clinician-scientist who develops treatments for diabetes, obesity, and intestinal disorders. A pioneer in diabetes treatment, Prof. Drucker’s work has provided important insights leading to the development of new drugs for the treatment of Type 2 diabetes. Currently, his laboratory at Lunenfeld-Tanenbaum focuses...Read more

Cardiology Management

Intensive-glycaemic-control-in-patients-with-type-2-diabetes

2019 14 Nov

Type 2 diabetes is very common not only in North America, but globally. The disorder can lead to severe limb and life-threatening complications if the blood glucose is not adequately controlled. When blood glucose levels remain elevated, it can lead to renal failure requiring dialysis, blindness, amputation of the lower extremity, peripheral neuropathy...Read more

Executive Health Management

New-management-pathways-in-cardiovascular-risk-factors

2019 02 Oct

Summary: A presentation of a case study in light of the updated ESC guidelines on lipid control and new guidelines on diabetes and cardiovascular disease. Several new guidelines were released at the European Society of Cardiology (ESC) Congress in Paris, France. These included updated guidelines on lipid control and new guidelines...Read more

IT Management

Uk-data-hubs-speed-up-new-meds-research

2019 01 Oct

The NHS has massive amounts of health data held within its various trusts and other facilities, and these "data silos" make it difficult for researchers and innovators to access and use important data about people's health. This problem will soon be a thing of the past as new data hubs – a total of seven – are set to be rolled out across the UK starting...Read more

Cardiology Management

Machine-learning-helps-predict-risk-of-heart-failure

2019 20 Sep

Heart failure is a common complication in patients suffering from Type 2 Diabetes (T2D). Recently, new medicines have been developed to offset these risks; however, finding effective strategies to identify which T2D patients are most at risk has been difficult.    Researchers at Brigham and Women’s Hospital and UT Southwestern Medical Centre have...Read more

Cardiology Management

Finding-the-sweet-spot-between-cardiovascular-and-diabetes-care

2019 01 Aug

Today in healthcare, more emphasis is being placed on treating the patient rather than a particular disease. In this sense, it is not unusual that the line between cardiology and diabetes care has become more blurred. As more cardiologists are finding themselves prescribing diabetes treatments, the need for interdisciplinary knowledge has become even...Read more

Cardiology Management

Ideal-cardiovascular-health-metrics-and-major-cardiovascular-events

2019 01 Aug

The prevalence of Type 2 diabetes has become a public health issue, as the International Diabetes Federation recorded a total of 425 million adults between the ages of 20 and 79 that had diabetes in 2017. The main cause of disability and mortality in this cohort is due to issues involving cardiovascular health. The American Heart Association has now...Read more

Executive Health Management

Precision-health-and-population-health-can-they-intersect-effectively

2019 22 May

How and where can precision medicine and public health join forces to improve patient care and outcomes and, ultimately, lead to more efficient healthcare. HealthManagement.org spoke to four precision medicine experts for their views. You might also like: Precision Medicine: the future of health   Tienush Rassaf  Department Head...Read more

Cardiology Management

Higher-bmi-increases-risk-of-serious-health-problems

2019 01 May

A new study has shed light on the link between higher body mass index (BMI) and serious health outcomes and death in over 2.8 million adults representative of the UK population. The new estimates, being presented at this year's European Congress on Obesity (ECO) in Glasgow, UK (28 April-1 May), indicate that adults with severe obesity class...Read more

Cardiology Management

Cardiologist-and-diabetologist-crosstalk

2018 20 Nov

The prevalence of Type 2 diabetes is consistently increasing, and the leading cause of death among diabetic patients continues to be cardiovascular diseases. Statistics show that coronary artery disease (CAD) accounts for 30% of deaths in the diabetic population. More than two-thirds of diabetic patients, 65 years and older, die because of vascular...Read more

Cardiology Management

Aha18-stress-doubles-the-risk-of-type-2-diabetes-in-women

2018 10 Nov

We are all aware that risk factors like obesity, high blood pressure, and an inactive/sedentary lifestyle can cause Type 2 diabetes. However, new research presented today at the American Heart Association Meeting 2018 in Chicago reveals that stress may also play a role in the development of this condition in women. Diabetes is a public health...Read more

Cardiology Management

Personalising-glucose-lowering-therapy-in-type-2-diabetes-and-cvd-patients

2018 21 Mar

Type 2 diabetes mellitus (T2DM) is a complex disease with a pathogenesis that is multidimensional. Recently, several specific glucose-lowering agents have been demonstrated to improve cardiovascular outcomes and may be favoured in T2DM patients with coexisting cardiovascular disease (CVD), according to a review paper in the journal Endocrinology and...Read more

Cardiology Management

Higher-bmi-increases-risk-of-chd-hypertension-type-2-diabetes

2017 06 Jul

New findings confirm previous evidence that higher body mass index (BMI) is associated with an increased risk of cardiometabolic diseases such as hypertension, coronary heart disease and Type 2 Diabetes. The study is published in JAMA Cardiology. Previously conducted observational studies have already established a connection between higher BMI and...Read more

Cardiology Management

Glycaemic-therapy-b-blockers-lower-mortality-risk-in-diabetes

2016 14 Nov

A study published in the journal Diabetes Care demonstrates that intensive glycaemic therapy (IGT) has beneficial effects in type 2 diabetes (T2D) patients receiving treatment with β -blockers.   See Also : Prevalence of Global Diabetes Seriously Underestimated Intensive glycaemic control (IGC) decreases...Read more

Cardiology Management

Pokemon-go-may-decrease-type-2-diabetes-burden

2016 26 Jul

According to leading diabetes researchers, the new smartphone craze Pokémon Go could prove to be an innovative solution to combat rising obesity levels and chronic disease. Pokémon Go is a virtual reality treasure hunt that requires players to walk to places within the real world and catch, train and batter monsters that appear on their mobile...Read more

Cardiology Management

Adults-born-with-heart-disease-at-risk-of-type-2-diabetes

2016 19 Jul

According to a new study, children born with heart disease have a higher risk of developing Type 2 diabetes after the age of 30. The study is published in the Journal of the American Heart Association. Study findings show that the risk is even higher for those born with a cyanotic congenital heart disease (CHD) condition. The study was conducted...Read more

IT Management

Ehrs-detect-undiagnosed-type-2-diabetes

2016 19 Feb

A group of UCLA researchers that mined thousands of electronic health records (EHRs) with the aim of finding a cheaper and more accurate way of identifying people with Type 2 diabetes discovered more than they expected. As well as developing a screening algorithm that could increase the number of correct Type 2 diabetes diagnoses of the...Read more

Cardiology Management

New-tools-determine-risk-of-chd-in-diabetics

2016 02 Feb

According to a recent report, new tools could be used for improving the treatment of heart disease in patients with type 2 diabetes. This could prove to be quite significant since nearly two-thirds of deaths among people with type 2 diabetes is related to cardiovascular disease. The report is published in the Journal of the American College of Cardiology:...Read more

Executive Health Management

Obesity-surgery-who-should-get-priority

2015 25 Sep

According to new research published in The Lancet Diabetes & Endocrinology, obese patients with type 2 diabetes, especially those with recent disease onset, should be prioritised for obesity surgery over those without type 2 diabetes.  Most healthcare systems typically prioritise obesity surgery on the basis of a person's BMI. Those with the highest...Read more

Executive Health Management

Pharmacists-play-critical-role-in-improving-patient-health

2015 18 Jun

According to a study conducted by Scot H. Simpson, professor in the faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta, pharmacists on primary care teams can have a significant impact on the treatment of blood pressure in patients with Type 2 diabetes. The study titled “Pharmacists on primary care teams: Effect on antihypertensive medication...Read more

Cardiology Management

Preventing-cvd-in-type-2-diabetes-patients

2015 10 Feb

Researchers have found that blood pressure (BP)-lowering treatment among patients with type 2 diabetes mellitus is associated with a lower risk of cardiovascular disease (CVD) and heart disease events and improved mortality. They noted that each 10-mm Hg lower systolic BP was associated with a lower risk of mortality, CVD events, coronary heart disease...Read more

Pharmacy Management

Once-daily-injection-approved-for-type-2-diabetes-and-moderate-ckd

2015 24 Jan

A once-daily injection has been approved in the UK for adults with type 2 diabetes and moderate renal impairment. Approximately one million people in the UK have type 2 diabetes and around 40 percent of them are affected by moderate chronic kidney disease. Renal impairment is one of the most common long-term complications associated with...Read more

Pharmacy Management

Sanofi-and-mannkind-to-launch-inhalable-insulin

2014 14 Nov

MannKind and Sanofi are set to launch their inhalable insulin product. Approved earlier this year by the FDA, Afrezza is a fast-acting insulin to be taken at mealtimes. The drug is effective for both Type 1 and Type 2 diabetes. Seven years ago, Pfizer launched Exubera, another inhalable insulin. When Exubera was introduced, it was believed to...Read more

Cardiology Management

Esc-type-2-diabetes-reversible-with-lifestyle-changes

2014 14 Nov

Type 2 diabetes can be reversed with lifestyle changes, according to European Society of Cardiology spokesperson Professor Eberhard Standl, from the Munich Diabetes Research Group in Germany. Today is World Diabetes Day and this year’s theme is Healthy Living and Diabetes. People can calculate their risk using a simple questionnaire and find out if...Read more

Executive Health Management

Diabetes-screening-urged-for-all-after-age-45

2014 14 Oct

The United States Preventive Services Task Force (USPSTF) has amended its recommendations on screening for diabetes following a review of current best evidence. According to the revised USPSTF guidelines, screening for diabetes and pre-diabetes should now be performed for all adults over at 45. USPSTF also recommends that uniform insurance coverage...Read more